FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 2619 - Tick-Borne Disease Working Group - Statutory (Congress Created)

GENERAL INFORMATION

Committee Name	Tick-Borne Disease Working Group	Agency Name	Department of Health and Human Services
Fiscal Year	2023	Committee Number	2619
Original Establishment Date	8/10/2017	Committee Status	Terminated
Actual Termination Date	12/13/2022	Committee URL	https://www.hhs.gov/ash/advisory-committees/tic...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	14
Terminated This FY	Yes	Designated Fed Officer Position Title*	Senior Advisor for Blood and Tissue Policy, Office of Infectious Disease and HIV/AIDS Policy
Merged This FY		Designated Federal Officer Prefix
Current Charter Date	8/10/2021	Designated Federal Officer First Name*	James
Date Of Renewal Charter	8/10/2023	Designated Federal Officer Middle Name	J
Projected Termination Date	12/13/2022	Designated Federal Officer Last Name*	Berger
Exempt From Renewal*	No	Designated Federal Officer Suffix	M.S., M.T.(ASCP), S.B.B.
Specific Termination Authority	Section 2062 of the 21st Century Cures Act	Designated Federal Officer Phone*	202 795-7608
Establishment Authority*	Statutory (Congress Created)	Designated Federal Officer Fax*	202 692-2101
Specific Establishment Authority*	Section 2062 of the 21st Century Cures Act	Designated Federal Officer Email*	james.berger@hhs.gov
Effective Date Of Authority*	12/13/2016
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	Scientific Technical Program Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Terminate
Legislation to Terminate Required	Yes
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The Working Group is charged to review ongoing activities and research related to tick-borne diseases conducted by HHS and other federal agencies, identify gaps in research and advances made, and provide a report to Congress and the HHS Secretary on its finding and recommendations every two years. The Working Group is also charged with soliciting input from States, localities, and nongovernmental entities, including organizations representing patients, health care providers, researchers, and industry. Subcommittees established by the Working Group research topic areas determined relevant to its charge and provide reports, including action items, for discussion and consideration by the Working Group for the biannual reports. The 2022 Report was delivered to Congress and the HHS Secretary in January 2023 and also posted on the HHS website for public access.
How is membership balanced?*	The Working Group comprises 14 members - seven federal members and seven public members. Federal members are required to consist of one or more representatives from the following HHS organizational components: Office of the Assistant Secretary for Health, Centers for Disease Control and Prevention, Food and Drug Administration, National Institutes of Health, and such other agencies and offices of HHS and other individuals as the Secretary determines appropriate and beneficial to the functioning of the Working Group. Other federal members represent the Centers for Medicare and Medicaid Services, Department of Defense, and the United States Department of Agriculture. Public members are required to represent the following categories: physicians and other health care providers with experience in diagnosing and treating tick-borne diseases; scientists or researchers with expertise; patients and their family members; and members of nonprofit organizations that advocate for patients with respect to tick-borne diseases.
How frequent & relevant are cmte mtgs?*	The Working Group is required to meet not less than two times a year. Three meetings were held in FY23 and focused on topics and issues that supported development of the 2022 report to the HHS Secretary and Congress, taking into consideration the 2018 and 2020 report.
Why advice can't be obtained elsewhere?*	The 21st Century Cures Act (Public Law 114-255), Section 2062 Tick-Borne Diseases, authorized the HHS Secretary to establish a Tick-Borne Disease Working Group. In general, the Working Group is to provide expertise and to review all efforts within HHS related to all tick-borne diseases and examine agency research priorities in order to help ensure interagency coordination and minimize overlap. Every two years, the Working Group is required to submit a report to Congress and the HHS Secretary on its findings and any recommendations for improving the federal response to tick-borne diseases. The final report was delivered to Congress in January 2023.
Why close or partially close meetings?	N/A
Recommendation Remarks	The authorizing legislation outlined a committee termination date of 12/13/2022 and in accordance with the legislation the committee was terminated on that date.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	No
Outcome Trust In Government	Yes	Action Reallocate Resources	No
Outcome Major Policy Changes	Yes	Action Issued New Regulations	No
Outcome Advance In Scientific Research	Yes	Action Proposed Legislation	Yes
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	Yes	Action Comment	Not applicable
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment		Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	Cost savings dependent on action taken on recommendations	Grants Review Comment	Not Applicable
Number Of Recommendations*	75	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	The 2018 Report to the HHS Secretary and Congress included 28 recommendations, the 2020 Report included 27 recommendations, and the 2022 Report included 20 recommendations.	Access Agency Website	Yes
% of Recs Fully Implemented*	2.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	Many of the recommendations require long-term action which cannot be accomplished in a fiscal year.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	15.00%	Access Publications	Yes
% of Recs Partially Implemented Comment	Many of the recommendations require long-term action which cannot be accomplished in a fiscal year.	Access Other	No
Agency Feedback*	Yes	Access Comment	N/A
Agency Feedback Comment*	HHS has the responsibility of ensuring the conduct of or support for epidemiological, basic, translational, and clinical research related to vector-borne diseases, including tick-borne diseases. Section 2062 of the 21st Century Cures Act mandated the Secretary of HHS establish the Tick-Borne Disease Working Group to review activities and research related to tick-borne diseases conducted by HHS and other federal agencies and provide a report to Congress and the HHS Secretary on its finding and recommendations every two years. The Working Group terminated in December 2022, six years after the date of enactment of the authorizing legislation. The public can view information on this Working Group at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/index.html.	Narrative Description*

COSTS

1. Payments to Non-Federal Members*	$0.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$0.00
2. Payments to Federal Members*	$10,337.04	2. Est. Payments to Fed Members Next FY*	$0.00
3. Payments to Federal Staff*	$142,376.00	3. Estimated Payments to Federal Staff*	$0.00
4. Payments to Consultants*	$0.00	4. Est. Payments to Consultants Next FY*	$0.00
5. Travel Reimb. For Non-Federal Membrs*	$0.00	5. Est Travel Reimb Non-Fed Membr nxtFY*	$0.00
6. Travel Reimb. For Federal Members*	$0.00	6. Est Travel Reimb For Fed Members*	$0.00
7. Travel Reimb. For Federal Staff*	$0.00	7. Est. Travel Reimb to Fed Staf Nxt FY*	$0.00
8. Travel Reimb. For Consultants*	$0.00	8. Est Travel Reimb to Consltnts Nxt FY*	$0.00
10. Other Costs	$161,220.00	10. Est. Other Costs Next FY*	$0.00
11. Total Costs	$313,933.04	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	8/16/2023 6:22 PM	Est. Fed Staff Support Next FY*	0.00
Federal Staff Support (FTE)*	2.00	Est Cost Remarks	No estimated costs in FY24 due to the committee terminating in FY23.
Cost Remarks

Interest Areas

Category Area Animals Veterinary Medicine Education Education Health Health Care Medical Education Medical Practitioners Public Health Safety Treatment Medicine Diseases Illnesses Medicine and Dentistry Research Research and Development Veterans Veterans and Veterans' Medical Care

Custom Links

Committee Level Reports